328 W. Claiborne St.
P.O. Box 964
Monroeville, Alabama 36460
(251) 575-4203
     
Women's Health
Resources
Basic InformationLatest News
Breast Cancer Drug Shows Long-Lasting Prevention PowerBreastfeeding May Bring Added Bonus for Women With MSHealth Tip: Heart Attack Symptoms in WomenIs Childbirth More Dangerous in Rural Areas?Good Workouts Might Extend a Woman's LifeMom-to-Be's Diabetes May Up Odds of Heart Disease in Her KidsMany Moms-to-Be Turn to Their Moms First for Medical AdviceStudy Links Hair Straighteners, Dyes to Breast CancerA Birth Control Pill You Take Just Once a Month?Birth Control Pill May Alter Part of Women's BrainsAHA News: Could Mammograms Screen for Heart Disease?Health Tip: Understanding the Menopausal TransitionSwitching Mammograms to Once Every 2 Years Could Come With RisksIt's Not Just Menopause to Blame for Older Women's Flagging Sex DriveAHA News: High Blood Pressure, Unhealthy Diets in Women of Childbearing AgeDiabetes Tougher on Women's HeartsAHA News: Treatment to Ward Off Stroke Less Effective in WomenMindfulness May Be a Balm for Breast Cancer PatientsKidney Injury on the Rise in Women Hospitalized During PregnancySome Jobs Are Better for Women's Hearts Than OthersEvening Meals Could Harm the Female Heart, Study ShowsSelf-Testing for Cervical Cancer Increases Screening RatesLong-Acting Birth Control in a Patch?Another Weight-Loss Surgery Benefit: Lower Breast Cancer RiskIt May Be Even Tougher for Women to Quit Smoking Than MenGet Moving: Exercise Can Help Lower Older Women's Fracture RiskFDA May Put Strong Warning on Breast ImplantsWhat to Do If You Have a Bad Reaction to CosmeticsMercury in Creams, Feces in Cosmetics: Beware Bargain Beauty ProductsStress in Pregnancy May Affect Baby's Sex, Preterm Delivery Risk: StudyIrregular Periods, Shorter Life Span?Moms' Weight-Loss Surgery Tied to Lower Risk of Birth DefectsHow Does Early Menopause Affect a Woman's Heart?Before Choosing an IUD for Birth Control, Know the FactsOnly a Third of Pregnant Women Getting Vaccinations They NeedHealth Tip: Relieving Hot FlashesDespite Rise in New Cases, Breast Cancer Deaths Continue to FallIs It Safe to Order Your Birth Control Online?Make All Hormonal Birth Control Available Without Prescription, Doctors' Group SaysStudy Links Menopausal Night Sweats to Impaired Thinking'Self-Silencing' Can Be Potentially Deadly for WomenMany Female Veterans Troubled by History of Sexual AssaultMore Hot Flashes Could Mean Higher Odds for Heart TroubleHysterectomy Procedure Tied to Worse Cancer OutcomesAHA News: These Diets Helped Women With Diabetes Cut Heart Attack, Stroke RiskHealth Tip: Gaining WeightHysterectomy Tied to Depression, AnxietyFirst Sexual Experience Was Forced for 1 in 16 U.S. WomenAHA News: Women With Heart Failure Less Likely to Get Heart Pump DeviceIs Your Pelvic Pain a Sign of Endometriosis?
LinksSelf-Help Groups
Related Topics

Wellness and Personal Development
Mental Disorders

Study Points to Harms From MRI 'Dye' in Early Pregnancy

HealthDay News
by -- Robert Preidt
Updated: Aug 20th 2019

new article illustration

TUESDAY, Aug. 20, 2019 (HealthDay News) -- A concerning number of U.S. women are exposed to the MRI contrast agent gadolinium early in pregnancy, a new study reveals.

In many cases, this exposure occurs before women know they're pregnant.

The researchers said their findings underscore the need for effective pregnancy screening measures before using gadolinium, which can cross the placenta and enter fetal circulation. The "dye" is used in nearly half of MRI exams in the United States to make organs and tissue more visible on the resulting images.

But its safety in pregnant women is unclear, and its use during pregnancy is not recommended unless it's crucial to the health of the mother or fetus. Research about the possible risk to fetuses has been inconsistent.

In this study, data on nearly 4.7 million live births in the United States between 2006 and 2017 found that gadolinium exposure occurred in one in 860 of those pregnancies. Most occurred during MRIs of the head, although researchers also reported a noteworthy number of pelvic and abdominal MRIs.

Nearly three-quarters of exposures occurred during the first trimester, according to the study published Aug. 20 in the journal Radiology.

"Unintended fetal exposures to gadolinium can occur during early pregnancy among women who are not yet aware they are pregnant. Increased attention to existing pregnancy screening measures may help reduce inadvertent exposures to gadolinium contrast," study lead author Steven Bird said in a journal news release.

Bird is an epidemiologist at the U.S. Food and Drug Administration.

His team pointed to several ways imaging centers could prevent inadvertent gadolinium exposure in pregnant women.

Those include using a written form or directly asking women if they could be pregnant, prominently displaying signs telling women to notify staff if they might be pregnant, and pregnancy testing when appropriate.

The FDA has advised all MRI centers to provide a medication guide to outpatients the first time they receive gadolinium.

Gadolinium is used in as many as 45% of MRI exams in the United States. Recent research suggests that trace levels of the dye may remain in the body after the MRI, but whether this poses risks remains unclear.

More information

RadiologyInfo.org has more on contrast agents.




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net